{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:58:18Z","timestamp":1792486698059,"version":"4.5.0"},"reference-count":164,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease of unknown etiology. It is characterized by the presence of rheumatoid factor and anticitrullinated peptide antibodies. The orchestra of the inflammatory process among various immune cells, cytokines, chemokines, proteases, matrix metalloproteinases (MMPs), and reactive oxidative stress play critical immunopathologic roles in the inflammatory cascade of the joint environment, leading to clinical impairment and RA. With the growing understanding of the immunopathogenic mechanisms, increasingly novel marked and potential biologic agents have merged for the treatment of RA in recent years. In this review, we focus on the current understanding of pathogenic mechanisms, highlight novel biologic disease-modifying antirheumatic drugs (DMRADs), targeted synthetic DMRADs, and immune-modulating agents, and identify the applicable immune-mediated therapeutic strategies of the near future. In conclusion, new therapeutic approaches are emerging through a better understanding of the immunopathophysiology of RA, which is improving disease outcomes better than ever.<\/jats:p>","DOI":"10.3390\/ijms20061332","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T12:18:53Z","timestamp":1552911533000},"page":"1332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis"],"prefix":"10.3390","volume":"20","author":[{"given":"Shyi-Jou","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Chenggong Rd., Neihu District, Taipei City 114, Taiwan"},{"name":"Department of Microbiology and Immunology, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"},{"name":"Department of Pediatrics, Penghu Branch of Tri-Service General Hospital, National Defense Medical Center, No. 90, Qianliao, Magong City, Penghu County 880, Taiwan"},{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Jiun","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Biology and Anatomy, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wun","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate Institute of Life Sciences, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University, No. 155, Section 2, Linong Street, Taipei City 112, Taiwan"},{"name":"Department of Neurology, Cheng Hsin General Hospital, No. 45, Cheng Hsin St., Pai-Tou, Taipei City 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Hsi","family":"Tien","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Chenggong Rd., Neihu District, Taipei City 114, Taiwan"},{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9208-0890","authenticated-orcid":false,"given":"Chih-Fen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Chenggong Rd., Neihu District, Taipei City 114, Taiwan"},{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ning","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Chenggong Rd., Neihu District, Taipei City 114, Taiwan"},{"name":"Department of Pediatrics, Penghu Branch of Tri-Service General Hospital, National Defense Medical Center, No. 90, Qianliao, Magong City, Penghu County 880, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Fu","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Chenggong Rd., Neihu District, Taipei City 114, Taiwan"},{"name":"Department of Pediatrics, Penghu Branch of Tri-Service General Hospital, National Defense Medical Center, No. 90, Qianliao, Magong City, Penghu County 880, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-7558","authenticated-orcid":false,"given":"Hueng-Chuen","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Chenggong Rd., Neihu District, Taipei City 114, Taiwan"},{"name":"Department of Pediatrics, Tungs\u2019 Taichung MetroHarborHospital, No. 699, Section 8, Taiwan Blvd., Taichung City 435, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"},{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"},{"name":"Graduate Institute of Life Sciences, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan"},{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, No. 35, Keyan Road, Zhunan, Miaoli County 350, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology andgenetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2013-204317","article-title":"Proposal fora new nomenclature of disease-modifying antirheumatic drugs","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/eji.201444486","article-title":"Autoimmune priming, tissue attack and chronic inflammation\u2014The three stages of rheumatoid arthritis","volume":"44","author":"Holmdahl","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-017-0634-0","article-title":"Cellular and molecular pathways of structural damage in rheumatoid arthritis","volume":"39","author":"Harre","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2016.02.010","article-title":"Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis","volume":"455","author":"Mateen","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/190552b0","article-title":"Agglutination of sensitized alligator erythrocytes by rheumatoid factor(s)","volume":"190","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrrheum.2018.10","article-title":"The B cell response to citrullinated antigens in the development of rheumatoid arthritis","volume":"14","author":"Scherer","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Jacques","year":"2014","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2016.132","article-title":"The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases","volume":"12","author":"Cuda","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_13","first-page":"68","article-title":"Th1-Th17 Ratio as a New Insight in Rheumatoid Arthritis Disease","volume":"17","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: An evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.intimp.2017.07.019","article-title":"Is macrophage polarization important in rheumatoid arthritis?","volume":"50","author":"Wang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cellimm.2013.01.010","article-title":"Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin","volume":"281","author":"Jaguin","year":"2013","journal-title":"Cell. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/ard.2007.078014","article-title":"Inflammasomes and rheumatic diseases: Evolving concepts","volume":"67","author":"Sidiropoulos","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the NLRP3 inflammasome pathway","volume":"11","author":"Groslambert","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.4110\/in.2018.18.e41","article-title":"Regulatory Roles of the Caspase-11 Non-Canonical Inflammasome in Inflammatory Diseases","volume":"18","author":"Yi","year":"2018","journal-title":"Immune Netw."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2018.22.1.1","article-title":"Role of inflammasomes in inflammatory autoimmune rheumatic diseases","volume":"22","author":"Yi","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00361-18","DOI":"10.1128\/IAI.00361-18","article-title":"Caspases-1 and caspase-11 mediate pyroptosis, inflammation, and control of Brucella joint infection","volume":"86","author":"Lacey","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_25","first-page":"35","article-title":"Dendritic cell subsets: Their roles in rheumatoid arthritis","volume":"33","author":"Lebre","year":"2008","journal-title":"Acta Reumatol. Port."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00296-011-2133-2","article-title":"Tolerogenic dendritic cells and rheumatoid arthritis: Current status and perspectives","volume":"32","author":"Zhao","year":"2012","journal-title":"Rheumatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.autrev.2015.01.014","article-title":"Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis","volume":"14","author":"Schinnerling","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrrheum.2009.185","article-title":"Dendritic cells as targets for therapy in rheumatoid arthritis","volume":"5","author":"Khan","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N","article-title":"Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation","volume":"28","author":"Sallusto","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_30","first-page":"48122","article-title":"A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization","volume":"277","author":"Latz","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","article-title":"Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells","volume":"93","author":"Steinbrink","year":"1999","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.4049\/jimmunol.177.9.5868","article-title":"\u201cAlternatively activated\u201d dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig","volume":"177","author":"Lan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fimmu.2017.01514","article-title":"Update on Dendritic Cell-Induced Immunological and Clinical Tolerance","volume":"8","author":"Obregon","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jung, S.M., Lee, J., Baek, S.Y., Lee, J., Jang, S.G., Hong, S.M., Park, J.S., Cho, M.L., Park, S.H., and Kwok, S.K. (2018). Fraxinellone Attenuates Rheumatoid Inflammation in Mice. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030829"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.4049\/jimmunol.143.12.3976","article-title":"A CD4 cell is capable of transferring suppression of collagen-induced arthritis","volume":"143","author":"Myers","year":"1989","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4049\/jimmunol.145.2.519","article-title":"T cell regulation of collagen-induced arthritis in mice. I. Isolation of Type II collagen-reactive T cell hybridomas with specific cytotoxic function","volume":"145","author":"Chiocchia","year":"1990","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/icb.2012.4","article-title":"T-cell receptor signaling and the pathogenesis of autoimmune arthritis: Insights from mouse and man","volume":"90","author":"Sakaguchi","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.1780401203","article-title":"Th1\/Th2 cytokine balance in arthritis","volume":"40","author":"Miossec","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/art.10832","article-title":"Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response","volume":"48","author":"Mauri","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2017.12.006","article-title":"Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis","volume":"87","author":"Tas","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Volin, M.V., and Shahrara, S. (2011). Role of TH-17 cells in rheumatic and other autoimmune diseases. Rheumatology, 1.","DOI":"10.4172\/2161-1149.1000104"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-011-0841-4","article-title":"IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis","volume":"90","author":"Pollinger","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2007.086066","article-title":"Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis","volume":"68","author":"Kelchtermans","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6894374","DOI":"10.1155\/2017\/6894374","article-title":"T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy","volume":"2017","author":"Dulic","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2012-202893","article-title":"Circulating plasmablasts\/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis","volume":"72","author":"Kerkman","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/art.40053","article-title":"Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission","volume":"69","author":"Pelzek","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1759720X18776224","article-title":"The role of the JAK\/STAT signal pathway in rheumatoid arthritis","volume":"10","author":"Malemud","year":"2018","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: The critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"643406","DOI":"10.1155\/2014\/643406","article-title":"TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice","volume":"2014","author":"Milanova","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.2010.138065","article-title":"Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation","volume":"70","author":"Wright","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: The sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20111908","article-title":"Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis","volume":"209","author":"Jaeger","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fimmu.2011.00052","article-title":"Macrophages in synovial inflammation","volume":"2","author":"Kennedy","year":"2011","journal-title":"Front. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2741\/1501","article-title":"Macrophage migration inhibitory factor in rheumatoid arthritis","volume":"10","author":"Morand","year":"2005","journal-title":"Front. Biosci. A J. Virtual Libr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuroscience.2012.08.041","article-title":"Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica","volume":"226","author":"Wang","year":"2012","journal-title":"Neuroscience"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.7150\/ijms.21773","article-title":"Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome","volume":"14","author":"Wang","year":"2017","journal-title":"Int. J. Med Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2015.00571","article-title":"The Interplay Between Monocytes\/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis","volume":"6","author":"Roberts","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3440281","article-title":"Calreticulin: One protein, one gene, many functions","volume":"344","author":"Michalak","year":"1999","journal-title":"Biochem. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.3390\/ijms15022916","article-title":"Soluble calreticulin induces tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 production by macrophages through mitogen-activated protein kinase (MAPK) and NFkappaB signaling pathways","volume":"15","author":"Duo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1186\/ar558","article-title":"The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction","volume":"4","author":"Burger","year":"2002","journal-title":"Arthritis Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4049\/jimmunol.180.1.655","article-title":"IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood","volume":"180","author":"Zrioual","year":"2008","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1073\/pnas.0808144106","article-title":"In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses","volume":"106","author":"Evans","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood-2011-03-341065","article-title":"T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets","volume":"118","author":"Alonso","year":"2011","journal-title":"Blood"},{"key":"ref_68","first-page":"177","article-title":"The importance of T cell interactions with macrophages in rheumatoid cytokine production","volume":"305","author":"Brennan","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152808786848360","article-title":"Regulatory T cells as targets for immunotherapy of autoimmunity and inflammation","volume":"7","author":"Hansen","year":"2008","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kishimoto, T., Kang, S., and Tanaka, T. (2015). IL-6: A New Era for the Treatment of Autoimmune Inflammatory Diseases. Rheumatol. Int., 131\u2013147.","DOI":"10.1007\/978-4-431-55651-0_11"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.iac.2017.01.002","article-title":"Immune Mechanisms and Novel Targets in Rheumatoid Arthritis","volume":"37","author":"Venuturupalli","year":"2017","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6","volume":"8","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/kep329","article-title":"Therapeutic targets in rheumatoid arthritis: The interleukin-6 receptor","volume":"49","author":"Dayer","year":"2010","journal-title":"Rheumatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"698313","DOI":"10.1155\/2014\/698313","article-title":"Interleukin 6 and rheumatoid arthritis","volume":"2014","author":"Yoshida","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00296-009-0953-0","article-title":"Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: Effect on the expression of chemokine and adhesion molecule","volume":"30","author":"Suzuki","year":"2010","journal-title":"Rheumatol. Int."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"765624","DOI":"10.1155\/2011\/765624","article-title":"The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis","volume":"2011","author":"Hashizume","year":"2011","journal-title":"Arthritis"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/rheumatology\/34.8.707","article-title":"Therapeutic monoclonal antibodies","volume":"34","author":"Choy","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1358\/dot.2018.54.3.2788019","article-title":"Rheumatoid arthritis: New monoclonal antibodies","volume":"54","author":"Serio","year":"2018","journal-title":"Drugs Today"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"New Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/DDDT.S139248","article-title":"Current perspective on rituximab in rheumatic diseases","volume":"11","author":"Schioppo","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_83","first-page":"967","article-title":"Serum sickness following a first rituximab infusion with no recurrence after the second one","volume":"26","author":"Mehsen","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3899\/jrheum.090442","article-title":"Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: Results from the SUNRISE trial","volume":"37","author":"Mease","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/annrheumdis-2013-203993","article-title":"Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study","volume":"74","author":"Emery","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Steeland, S., Libert, C., and Vandenbroucke, R.E. (2018). A New Venue of TNF Targeting. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201804.0015.v1"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.3748\/wjg.v22.i42.9300","article-title":"Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases","volume":"22","author":"Billmeier","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ibd.20225","article-title":"Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor alpha agents","volume":"13","author":"Nesbitt","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_90","first-page":"673","article-title":"Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature","volume":"26","author":"Levy","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.clinthera.2018.04.016","article-title":"B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-alpha Agents on B Lymphocytes: A Review of the Literature","volume":"40","author":"Pala","year":"2018","journal-title":"Clin. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kotyla, P.J. (2018). Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061739"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: Past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imm.12142","article-title":"Interleukin-17A: A unique pathway in immune-mediated diseases: Psoriasis, psoriatic arthritis and rheumatoid arthritis","volume":"141","author":"Kirkham","year":"2014","journal-title":"Immunology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.38343","article-title":"Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010","volume":"66","author":"Leipe","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"PHOENIX 1 Study Investigators. Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1501646","article-title":"A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis","volume":"373","author":"Gordon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2016-209831","article-title":"A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_102","first-page":"2120","article-title":"FDA approves tofacitinib for rheumatoid arthritis","volume":"69","author":"Traynor","year":"2012","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2017.04.015","article-title":"Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats","volume":"184","author":"Gertel","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00281-017-0623-3","article-title":"Future therapeutic targets in rheumatoid arthritis?","volume":"39","author":"Cheung","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/13696998.2016.1275653","article-title":"Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis","volume":"20","author":"Chastek","year":"2017","journal-title":"J. Med Econ."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Brief report: Inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12017","article-title":"Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients","volume":"171","author":"Pesce","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/art.38714","article-title":"Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: Comment on the article by Thiolat et al","volume":"66","author":"Sarantopoulos","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/14397595.2014.914016","article-title":"Effects of anti-IL-6 receptor antibody on human monocytes","volume":"25","author":"Tono","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/annrheumdis-2013-204405","article-title":"Sarilumab, a fully human monoclonal antibody against IL-6Ralpha in patients with rheumatoid arthritis and an inadequate response to methotrexate: Efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial","volume":"73","author":"Huizinga","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.39093","article-title":"Sarilumab Plus Methotrexate in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study","volume":"67","author":"Genovese","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e000607","DOI":"10.1136\/rmdopen-2017-000607","article-title":"Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: A biomarker substudy of the phase 3 TARGET study","volume":"4","author":"Gabay","year":"2018","journal-title":"RMD Open"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fimmu.2018.01510","article-title":"Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System","volume":"9","author":"Kubo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-017-0856-4","article-title":"Baricitinib: A Review in Rheumatoid Arthritis","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"ref_115","first-page":"379","article-title":"Abatacept for the treatment of rheumatoid arthritis: A review, Current therapeutic research","volume":"68","author":"Kaine","year":"2007","journal-title":"Clin. Exp."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/08830185.2018.1465943","article-title":"Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis","volume":"37","author":"Langdon","year":"2018","journal-title":"Int. Rev. Immunol."},{"key":"ref_117","first-page":"562","article-title":"Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis","volume":"35","author":"Larghi","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"304ps18","DOI":"10.1126\/scitranslmed.aaa7721","article-title":"Hurdles in therapy with regulatory T cells","volume":"7","author":"Trzonkowski","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/imm.12811","article-title":"Targeting of tolerogenic dendritic cells towards heat-shock proteins: A novel therapeutic strategy for autoimmune diseases?","volume":"153","author":"Jansen","year":"2018","journal-title":"Immunology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1084\/jem.175.6.1805","article-title":"Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis","volume":"175","author":"Boog","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI2465","article-title":"Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs","volume":"102","author":"Schett","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/BOR.0b013e32835cfc16","article-title":"Vitamin D deficiency and risk for rheumatic diseases: An update","volume":"25","author":"Gatenby","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12016-016-8577-0","article-title":"Vitamin D Deficiency and Rheumatoid Arthritis","volume":"52","author":"Ishikawa","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1479-5876-9-89","article-title":"Comparative study of clinical grade human tolerogenic dendritic cells","volume":"9","author":"Onate","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3389\/fimmu.2017.01279","article-title":"Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_128","first-page":"316","article-title":"MicroRNA signature of regulatory T cells in health and autoimmunity","volume":"100","author":"Shahbazi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2010.02.005","article-title":"The role of microRNA in rheumatoid arthritis and other autoimmune diseases","volume":"136","author":"Furer","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis","volume":"8","author":"Alivernini","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: A protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Wu, M.H., Tsai, C.H., Huang, Y.L., Fong, Y.C., and Tang, C.H. (2018). Visfatin Promotes IL-6 and TNF-\u03b1 Production in Human Synovial Fibroblasts by Repressing miR-199a-5p through ERK, p38 and JNK Signaling Pathways. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010190"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1096\/fj.09-135160","article-title":"PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis","volume":"23","author":"Hayer","year":"2009","journal-title":"FASEB J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri2036","article-title":"PI3K delta and PI3K gamma: Partners in crime in inflammation in rheumatoid arthritis and beyond?","volume":"7","author":"Rommel","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Nandakumar, K.S. (2018). Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030677"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Boutet, M.A., Nerviani, A., Gallo Afflitto, G., and Pitzalis, C. (2018). Role of the IL-23\/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020530"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/art.30326","article-title":"Transforming growth factor beta-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg\/Th17 cells and osteoclastogenesis","volume":"63","author":"Park","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_138","first-page":"911","article-title":"Cell therapies for refractory rheumatoid arthritis","volume":"36","author":"Liu","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/intimm\/dxt008","article-title":"Histamine 4 receptor plays an important role in auto-antibody-induced arthritis","volume":"25","author":"Nent","year":"2013","journal-title":"Int. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1007\/s00296-011-2069-6","article-title":"Lower expression of histamine H(4) receptor in synovial tissues from patients with rheumatoid arthritis compared to those with osteoarthritis","volume":"32","author":"Yamaura","year":"2012","journal-title":"Rheumatol. Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/ard.2011.154211","article-title":"Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay","volume":"71","author":"Grabiec","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: Emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenetics"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/annrheumdis-2015-209064","article-title":"Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes","volume":"76","author":"Angiolilli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20041545","article-title":"Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes","volume":"200","author":"Valencia","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13075-015-0647-9","article-title":"Evidence for cadherin-11 cleavage in the synovium and partial characterization of its mechanism","volume":"17","author":"Noss","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2017.01.008","article-title":"Cadherin-11 as a therapeutic target in chronic, inflammatory rheumatic diseases","volume":"176","author":"Sfikakis","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1470-2045(08)70217-1","article-title":"Role of oestrogen in the development of joint symptoms?","volume":"9","author":"Tan","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Kass, A., Hollan, I., Fagerland, M.W., Gulseth, H.C., Torjesen, P.A., and Forre, O.T. (2015). Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139439"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fimmu.2018.00749","article-title":"Transcription Factor SOX5 Promotes the Migration and Invasion of Fibroblast-Like Synoviocytes in Part by Regulating MMP-9 Expression in Collagen-Induced Arthritis","volume":"9","author":"Shi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/1529-0131(200005)43:5<1134::AID-ANR24>3.0.CO;2-#","article-title":"Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte\/macrophages: A possible role in rheumatoid arthritis","volume":"43","author":"Jovanovic","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_152","first-page":"1918","article-title":"Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis","volume":"30","author":"Blaschke","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_153","first-page":"64","article-title":"Synergistic induction of CX3CL1 by interleukin-1beta and interferon-gamma in human lung fibroblasts: Involvement of signal transducer and activator of transcription 1 signaling pathways","volume":"157","author":"Isozaki","year":"2011","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/14397595.2016.1213481","article-title":"Fractalkine\/CX3CL1 in rheumatoid arthritis","volume":"27","author":"Nanki","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13075-016-1128-5","article-title":"A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease","volume":"18","author":"Hatterer","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/eji.201444908","article-title":"HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1alpha activation","volume":"45","author":"Park","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_157","first-page":"2619","article-title":"DFMG attenuates the activation of macrophages induced by coculture with LPCinjured HUVE12 cells via the TLR4\/MyD88\/NFkappaB signaling pathway","volume":"41","author":"Cong","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00296-018-4074-5","article-title":"Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases","volume":"38","author":"Deuteraiou","year":"2018","journal-title":"Rheumatol. Int."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semarthrit.2015.06.003","article-title":"Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis","volume":"45","author":"Borie","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/TCRM.S167109","article-title":"A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus","volume":"14","author":"Ishikawa","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections","volume":"13","author":"Casulo","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10067-014-2562-x","article-title":"Late-onset neutropenia following rituximab treatment for rheumatologic conditions","volume":"33","author":"Breuer","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/imt-2017-0065","article-title":"Abatacept and granulocyte-colony stimulating factor in a patient with rheumatoid arthritis and neutropenia","volume":"9","author":"Priora","year":"2017","journal-title":"Immunotherapy"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"23910","DOI":"10.3390\/ijms141223910","article-title":"Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-alpha and IL-1beta in PBMCs","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/6\/1332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:38:21Z","timestamp":1760186301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/6\/1332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":164,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijms20061332"],"URL":"https:\/\/doi.org\/10.3390\/ijms20061332","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]}}}